Agreement for clinical trials

Héphaïstos has found an agreement within one of the largest French hospital structures – specialized in cancer screening – to start clinical trials of its first cancer detection module.

We are certain that this agreement will strengthen Héphaïstos’ future prospects, confirming its seriousness and bringing together the two worlds: Artificial Intelligence and the innovative hospital.

Clinical trials are expected to start in late March.